Abstract
Objective
To assess the long-term efficacy and safety of bilateral subthalamic nucleus (STN) stimulation in patients with advanced Parkinson’s disease (PD).
Methods
42 consecutive patients with idiopathic PD treated with bilateral STN stimulation were enrolled. Parkinsonian status, medication intake and neuropsychological evaluation were assessed preoperatively and at 1 and 5 years postoperatively in on and off medication/on and off stimulation conditions.
Results
23 patients could be followed-up 5 years after surgery. In the remaining cases, 5 died, 1 could not be assessed because of device removal for infection, 1 decided not to be stimulated, and 11 were lost of follow-up (one because of a liver carcinoma and the others because they refused the formal four conditions of assessment). STN stimulation reduced the UPDRS motor score by 55 % compared to baseline in the offmedication conditions. Tremor, rigidity, bradykinesia, postural stability, and gait improved by 74 %, 66 %, 59 %, 17 % and 37 %, respectively. UPDRS part II scores were reduced by 38 %. The dopaminergic treatment daily dose was reduced by 54.4 % after surgery. Axial dopa-unresponsive signs worsened in some patients. Among the 42 initial patients we observed the following: 2 brain hemorrhages, 3 infections of the device, 2 phlebitis and 1 pulmonary embolism. In addition, 2 patients needed a repositioning of the electrode. Among the 23 patients followed at 5 years, long lasting side effects consisted in dysarthria (56 %), depression (39 %), eyelid opening apraxia (30.4 %) and apathy (4.3 %).
Conclusions
Our data confirm that bilateral STN stimulation is beneficial in the long-term for PD patients but does not prevent disease progression and the occurence of axial levodopa unresponsive signs in some patients.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP (2005) Pallidal vs Subthalamic nucleus deep brain stimulation in Parkinson disease. Arch Neurol 62:554–560
Appleby BS, Duggan PS, Regenberg A, Rabins PV (2007) Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: A metaanalysis of ten years’ experience. Mov Disord 22(12):1722–1728
Ardouin C, Pillon B, Peiffer E, Bejjani P, Limousin P, Damier P, Arnulf I, Benabid AL, Agid Y, Pollak P (1999) Bilateral subthalamic or pallidal stimulation for Parkinson’s disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol 46(2):217–223
Bejjani BP, Dormont D, Pidoux B, Yelnik J, Damier P, Arnulf I, Bonnet AM, Marsault C, Agid Y, Philippon J, Cornu P (2000) Bilateral subthalamic stimulation for Parkinson’s disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg 92(4):615–625
Capecci M, Ricciuti RA, Burini D, Bombace VG, Provinciali L, Iacoangeli M, Scerrati M, Ceravolo MG (2005) Functional improvement after subthalamic stimulation in Parkinson’s disease: a non-equivalent controlled study with 12–24 month follow up. J Neurol Neurosurg Psychiatry 76:769–774
Capus L, Melatini A, Zorzon M, Torre P, Carraro N, Moretti D, Gioulis M, Moretti R, Sarra MV, Marsala SZ (2001) Chronic bilateral electrical stimulation of the subthalamic nucleus for the treatment of advanced Parkinson’s disease. Neurol Sci 22(1):57–58
Contarino MF, Daniele A, Sibilia AH, Romito LM, Bentivoglio AR, Gainotti G, Albanese A (2007) Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 78(3):248–252
Czernecki V, Pillon B, Houeto JL, Welter ML, Mesnage V, Agid Y, Dubois B (2005) Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson’s disease? J Neurol Neurosurg Psychiatry 76:775–779
Deep brain stimulation study group (2001) Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. N Engl J Med 345(13):956–963
Derost PP, Ouchchane L, Morand D, Ulla M, Llorca PM, Barget M, Debilly B, Lemaire JJ, Durif F (2007) Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population? Neurology 68(17):1345–1355
Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schafer H, Botzel K, Daniels C, Deutschlander A, Dillmann U, Eisner W, Gruber D, Hamel W, Herzog J, Hilker R, Klebe S, Kloss M, Koy J, Krause M, Kupsch A, Lorenz D, Lorenzl S, Mehdorn HM, Moringlane JR, Oertel W, Pinsker MO, Reichmann H, Reuss A, Schneider GH, Schnitzler A, Steude U, Sturm V, Timmermann L, Tronnier V, Trottenberg T, Wojtecki L, Wolf E, Poewe W, Voges J; German Parkinson Study Group (2006) Neurostimulation Section. A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med 355(9):896–908
Esselink RA, de Bie RM, de Haan RJ, Lenders MW, Nijssen PC, Staal MJ, Smeding HM, Schuurman PR, Bosch DA, Speelman JD (2004) Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomised trial. Neurology 62(2):201–207
Fahn S, Elton RL for the UPDRS Development Commitee (1987) Unified Parkinson’s disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M (eds) Recent development in Parkinson’s disease. Vol 2. Florham Park, NJ: Mac Millan Healthcare Information, pp 153–163
Faist M, Xie J, Kurz D, Berger W, Maurer C, Pollak P, Lucking CH (2001) Effect of bilateral subthalamic nucleus stimulation on gait in Parkinson’s disease. Brain 124:1590–1600
Ford B, Winfield L, Pullman SL, Frucht SJ, Du Y, Greene P, Cheringal JH, Yu Q, Cote LJ, Fahn S, McKhann II GM, Goodman RR (2004) Subthalamic nucleus stimulation in advanced Parkinson’s disease: blinded assessments at one year follow up. J Neurol Neurosurg Psychiatry 75:1255–1259
Fraix V, Pollak P, Van Blercom N, Xie J, Krack P, Koudsie A, Benabid AL (2000) Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson’s disease. Neurology 55(12):1921–1923
Funkiewiez A, Ardouin C, Caputo E, Krack P, Fraix V, Klinger H, Chabardes S, Foote K, Benabid AL, Pollak P (2004) Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson’s disease. J Neurol Neurosurg Psychiatry 75(6):834–839
Gan J, Xie-Brustolin J, Mertens P, Polo G, Klinger H, Mollion H, Benatru I, Henry E, Broussolle E, Thobois S (2007) Bilateral subthalamic nucleus stimulation in advanced Parkinson’s disease: three years follow-up. J Neurol 254(1):99–106
Hilker R, Portman AT, Voges J, Staal MJ, Burghaus L, van Laar T, Koulousakis A, Maguire RP, Pruim J, de Jong BM, Herholz K, Sturm V, Heiss WD, Leenders KL (2005) Disease progression continues in patients with advanced Parkinson’s disease and effective subthalamic nucleus stimulation. J Neurol Neurosurg Psychiatry 76:1217–1221
Herzog J, Volkmann J, Krack P, Kopper F, Potter M, Lorenz D, Steinbach M, Klebe S, Hamel W, Schrader B, Weinert D, Muller D, Mehdorn HM, Deuschl G (2003) Two-year follow-up of subthalamic deep brain stimulation in Parkinson’s disease. Mov Disord 18(11):1332–1337
Houeto JL, Damier P, Bejjani PB, Staedler C, Bonnet AM, Arnulf I, Pidoux B, Dormont D, Cornu P, Agid Y (2000) Subthalamic stimulation in Parkinson disease: a multidisciplinary approach. Arch Neurol 57(4):461–465
Houeto JL, Mesnage V, Mallet L, Pillon B, Gargiulo M, du Moncel ST, Bonnet AM, Pidoux B, Dormont D, Cornu P, Agid Y (2002) Behavioural disorders, Parkinson’s disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry 72(6):701–707
Kleiner-Fisman G, Fisman DN, Sime E, Saint-Cyr JA, Lozano AM, Lang AE (2003) Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. J Neurosurg 99:489–495
Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, Lang AE, Deuschl G (2006) Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 21(Suppl 14):S290–S304
Krack P, Pollak P, Limousin P, Hoffmann D, Xie J, Benazzouz A, Benabid AL (1998) Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson’s disease. Brain 121:451–457
Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, Koudsie A, Limousin PD, Benazzouz A, LeBas JF, Benabid AL, Pollak P (2003) Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 349:1925–1934
Kumar R, Lozano AM, Kim YJ, Hutchison WD, Sime E, Halket E, Lang AE (1998) Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson’s disease. Neurology 51(3):850–855
Liang GS, Chou KL, Baltuch GH, Jaggi JL, Loveland-Jones C, Leng L, Maccarone H, Hurtig HI, Colcher A, Stern MB, Kleiner-Fisman G, Simuni T, Siderowf AD (2006). Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson’s disease. Stereotact Funct Neurosurg 84(5–6):221–227
Limousin P, Krack P, Pollack P, Benazzouz A, Ardouin C, Hoffmann D, Benabid AL (1998) Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 339(16):1105–1111
Limousin P, Pollack P, Benazzouz A, Hoffmann D, Le Bas JF, Broussolle E, Perret JE, Benabid AL (1995) Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 345(8942):91–95
Lopiano L, Rizzone M, Bergamasco B, Tavella A, Torre E, Perozzo P, Valentini MC, Lanotte M (2001) Deep brain stimulation of the subthalamic nucleus: clinical effectiveness and safety. Neurology 56:552–554
Molinuevo JL, Valldeoriola F, Tolosa E, Rumia J, Valls-Sole J, Roldan H, Ferrer E (2000) Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease. Arch Neurol 57(7):983–988
Moro E, Scerrati M, Romito LM, Roselli R, Tonali P, Albanese A (1999) Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson’s disease. Neurology 53(1):85–90
Ostergaard K, Sunde N, Dupont E (2002) Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson’s disease and motor fluctuations. Mov Disord 17(4):693–700
Ostergaard K, Sunde N (2006) Evolution of Parkinson’s disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus. Mov Disord 21(5):624–631
Pahwa R, Wilkinson SB, Overman J, Lyons KE (2003) Bilateral subthalamic stimulation in patients with Parkinson disease: long-term follow-up. J Neurosurg 99(1):71–77
Pinter MM, Alesch F, Murg M,Seiwald M, Helscher RJ, Binder H (1999) Deep brain stimulation of the subthalamic nucleus for control of extrapyramidal features in advanced idiopathic Parkinson’s disease: one year follow-up. J Neural Transm 106:693–709
Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto J-L, Pollak P, Rehncrona S, Kulisevsky J, Albanese A, Volkmann J, Hariz MI, Quinn NP, Speelman JD, Guridi J, Zamarbide I, Gironell A, Molet J, Pascual-Sedano B, Pidoux B, Bonnet AM, Agid Y, Xie J, Benabid A-L, Lozano AM, Saint Cyr J, Romito L, Contarino F, Scerrati M, Fraix V, Van Blercom N (2005) Bilateral deep brain stimulation in Parkinson’s disease: a multicentre study with 4 years followup. Brain 128:2240–2249
Romito LM, Scerrati M, Contarino MF, Bentivoglio AR, Tonali P, Albanese A (2002) Long-term follow up of subthalamic nucleus stimulation in Parkinson’s disease. Neurology 58(10):1546–1550
Russmann H, Ghika J, Villemure JG, Robert B, Bogousslavsky J, Burkhard PR, Vingerhoets FJ (2004) Subthalamic nucleus deep brain stimulation in P arkinson disease patients over age 70 years old. Neurology 65:179–180
Schupbach WM, Chastan N, Welter ML, Houeto JL, Mesnage V, Bonnet AM, Czernecki V, Maltete D, Hartmann A, Mallet L, Pidoux B, Dormont D, Navarro S, Cornu P, Mallet A, Agid Y (2005). Stimulation of the subthalamic nucleus in Parkinson’s disease: a 5 year follow-up. J Neurol Neurosurg Psychiatry 76:1640–1644
Schupbach WM, Maltete D, Houeto JL, du Montcel ST, Mallet L, Welter ML, Gargiulo M, Behar C, Bonnet AM, Czernecki V, Pidoux B, Navarro S, Dormont D, Cornu P, Agid Y (2007) Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology 23; 68(4):267–271
Scotto di Luzio AE, Ammannati F, Marini P, Sorbi S, Mennonna P (2001) Which target for DBS in Parkinson’s disease? Subthalamic nucleus versus globus pallidus internus. Neurol Sci 22(1):87–88
Simuni T, Jaggi JL, Mulholland H, Hurtig H, Colcher A, Siderowf AD, Ravina B, Skolnick BE, Goldstein R, Stern MB, Baltuch GH (2002) Bilateral stimulation of the subthalamic nucleus in patients with Parkinson disease: a study of efficacy and safety. J Neurosurg 96:666–672
Thobois S, Mertens P, Guenot M, Hermier M, Mollion H, Bouvard M, Chazot G, Broussolle E, Sindou M (2002) Subthalamic nucleus stimulation in Parkinson’s disease: clinical evaluation of 18 patients. J Neurol 249:529–534
Thobois S, Corvaisier S, Mertens P, Di Guardo C, Mollion H, Guenot M, Rochefort F, Chazot G, Sindou M, Broussolle E (2003) The timing of antiparkinsonian treatment reduction after subthalamic nucleus stimulation. Eur Neurol 49(1):59–63
Thobois S (2006). Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson’s disease: A review of the literature. Clinical Therapeutics 28:1–12
Tir M, Devos D, Blond S, Touzet G, Reyns N, Duhamel A, Cottencin O, Dujardin K, Cassim F, Destee A, Defebvre L, Krystkowiak P (2007) Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients. Neurosurgery 61(2):297–304
Visser-Vandewalle V, van der Linden C, Temel Y, Celik H, Ackermans L, Spincemaille G, Caemaert J (2005) Long-term effects of bilateral subthalamic nucleus stimulation in advanced Parkinson disease: a four year follow-up. Parkinsonism and Related disease 11:157–165
Vingerhoets FJ, Villemure JG, Temperli P, Pollo C, Pralong E, Ghika J (2002) Subthalamic DBS replaces levodopa in Parkinson’s disease: two-year followup Neurology 58(3):396–401
Volkmann J, Allert N, Voges J, Weiss PH, Freund HJ, Sturm V (2001) Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology 56:548–551
Wider C, Pollo C, Bloch J, Burkhard PR, Vingerhoets FJ (2008) Long-term outcome of 50 consecutive Parkinson’s disease patients treated with subthalamic deep brain stimulation. Parkinsonism Relat Disord 14(2):114–119
Terao T, Takahashi H, Yokochi F, Taniguchi M, Okiyama R, Hamada I (2003). Hemorrhagic complication of stereotactic surgery in patients with movement disorders. J Neurosurg 98(6):1241–1246
Czernecki V, Schupbach M, Yaici S, Levy R, Bardinet E, Yelnik J, Dubois B, Agid Y (2008) Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom. Mov Disord 23(7):964–969
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gervais-Bernard, H., Xie-Brustolin, J., Mertens, P. et al. Bilateral subthalamic nucleus stimulation in advanced Parkinson’s disease: Five year follow-up. J Neurol 256, 225–233 (2009). https://doi.org/10.1007/s00415-009-0076-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-009-0076-2